U.S. sends 3 million J&J COVID-19 vaccine doses to Brazil

U.S. sends 3 million J&J COVID-19 vaccine doses to brazil

The United States is sending 3 million doses of the Johnson & Johnson' COVID-19 vaccine to Brazil, as that country struggles with a surge in cases and its death toll climbs above 500,000.

Less than a third of Brazil's population has had at least one shot, and an average of 74,490 new cases per day were reported in the country in the last week—an increase of 26 percent from the average two weeks ago, The New York Times reported.

The Johnson & Johnson vaccine, which confers a high level of protection against virus cases, hospitalizations, and deaths, has faced sagging demand in the United States. Both the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration in April recommended a pause in its use after reports of a rare blood-clotting disorder in a small number of people who had received the vaccine. That decision dampened interest in the shot, have said, The Times reported.

The vaccines will arrive in Brazil on Thursday and are part of President Joe Biden's promise to send 80 million doses of COVID-19 vaccines to other nations by the end of the month, a White House official said, The Times reported.

Last weekend, the United States sent 2.5 million doses of the Moderna vaccine to Taiwan. Biden announced this month that the United States would buy 500 million doses of the Pfizer COVID-19 vaccine and send those to roughly 100 countries during the next year, The Times reported.


Explore further

US announces allocation plan for 55 mn COVID vaccine doses

More information: The New York Times Article

Copyright © 2021 HealthDay. All rights reserved.

Citation: U.S. sends 3 million J&J COVID-19 vaccine doses to Brazil (2021, June 25) retrieved 15 October 2021 from https://medicalxpress.com/news/2021-06-million-jj-covid-vaccine-doses.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors